Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Hecht

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Studies in Health Technology and Informatics|May 23, 2026
GlobalMedQA: A Standardized Multilingual Dataset for Assessing Medical Knowledge in LLMsMário Macedo, Manuel Hecht, Sylvia Saalfeld, et al.
BMC Medical Research Methodology|March 27, 2025
Investigator-initiated versus industry-sponsored trials - visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT)Manuel Hecht, Anette Blümle, Harald Binder, et al.
ESC Heart Failure|May 8, 2026
Low cardiovascular event rates in patients treated with CAR T-cells: Real-world outcomes from two independent cohortsJakob Christoph Voran, Lars Fransecky, Hatim Seoudy, et al.
The Lancet Regional Health. Europe|October 29, 2025
Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysisDavid Baden, Nadine Wolgast, Philipp M Altrock, et al.
Nature Communications|November 27, 2022
High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infectionEva-Maria Jacobsen, Dorit Fabricius, Magdalena Class, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Studies in Health Technology and Informatics|May 23, 2026
GlobalMedQA: A Standardized Multilingual Dataset for Assessing Medical Knowledge in LLMsMário Macedo, Manuel Hecht, Sylvia Saalfeld, et al.
BMC Medical Research Methodology|March 27, 2025
Investigator-initiated versus industry-sponsored trials - visibility and relevance of randomized controlled trials in clinical practice guidelines (IMPACT)Manuel Hecht, Anette Blümle, Harald Binder, et al.
ESC Heart Failure|May 8, 2026
Low cardiovascular event rates in patients treated with CAR T-cells: Real-world outcomes from two independent cohortsJakob Christoph Voran, Lars Fransecky, Hatim Seoudy, et al.
The Lancet Regional Health. Europe|October 29, 2025
Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysisDavid Baden, Nadine Wolgast, Philipp M Altrock, et al.
Nature Communications|November 27, 2022
High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infectionEva-Maria Jacobsen, Dorit Fabricius, Magdalena Class, et al.
Pageof 1